Brenipatide

N/A

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameBrenipatide
Drug Alias NameLY3537031LY-3537031
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucose-Dependent Insulinotropic Polypeptide Receptor agonists
TargetsGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide Receptor
Therapy Area/IndicationsSchizophreniaDepressive Disorder, MajorDepressive Disorder +[19] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[24] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesEli Lilly And Company
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesIncog Biopharma Services IncEli Lilly And CompanyLilly Suzhou Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophreniaDepressive Disorder, MajorDepressive Disorder +[19] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A